北新路橋(002307.SZ):北新投資、兵團交建擬引進中國信達進行增資並實施市場化債轉股
格隆匯12月14日丨北新路橋(002307.SZ)公佈,公司所屬子公司新疆北新投資建設有限公司(“北新投資”)、新疆生產建設兵團交通建設有限公司(“兵團交建”)擬引進中國信達資產管理股份有限公司(“中國信達”)進行增資並實施市場化債轉股,增資金額不超過4.5億元、4900萬元,上述合計不超過4.99億元,全部由中國信達以現金形式出資。
公司通過開展債轉股業務,引入長期權益性資金,全部增資款將用於償還標的公司各自存量金融負債。此次債轉股可以有效降低資產負債率和帶息負債規模,調整優化資產負債結構。此次債轉股完成後,公司帶息負債減少,對公司財務狀況和經營成果產生積極影響,有利於提升公司核心競爭力和可持續健康發展能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.